Specialty Clinics are expected to witness the fastest growth at a CAGR of 9.6% from 2026 to 2033, supported by rising demand for personalized diabetes care, increasing obesity management services, expanding endocrinology practices, and growing adoption of innovative GLP-1-based treatment protocols
Heres what makes this product stand out: its built around specific, targeted strainsAkkermansia muciniphila, Clostridium butyricum, and Bifidobacterium infantis
In other words, the researchers looked at the treated group only after they were exposed to GLP-1s, when their BMIs had likely fallen lower than their pre-prescription weights, the commentary writers noted
But like all medications, side effects are possible when taking GLP-1s
Research is revealing even more complexities around how Alzheimers and other diseases cause dementia